Correlation Between Adhera Therapeutics and NeuroSense Therapeutics

Can any of the company-specific risk be diversified away by investing in both Adhera Therapeutics and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adhera Therapeutics and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Adhera Therapeutics and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Adhera Therapeutics and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adhera Therapeutics with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adhera Therapeutics and NeuroSense Therapeutics.

Diversification Opportunities for Adhera Therapeutics and NeuroSense Therapeutics

0.0

Correlation Coefficient

Adhera Therapeutics  NeuroSense Therapeutics

Pay attention - limited upside

The 3 months correlation between Adhera and NeuroSense is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Adhera Therapeutics and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Adhera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adhera Therapeutics are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Adhera Therapeutics i.e., Adhera Therapeutics and NeuroSense Therapeutics go up and down completely randomly.

Pair Corralation between Adhera Therapeutics and NeuroSense Therapeutics

If you would invest  44.00  in NeuroSense Therapeutics Ltd on December 29, 2024 and sell it today you would lose (23.00) from holding NeuroSense Therapeutics Ltd or give up 52.27% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Adhera Therapeutics  vs.  NeuroSense Therapeutics Ltd

Adhera Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Adhera Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Adhera Therapeutics is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

NeuroSense Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in NeuroSense Therapeutics Ltd are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, NeuroSense Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Adhera Therapeutics and NeuroSense Therapeutics

The main advantage of trading using opposite Adhera Therapeutics and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adhera Therapeutics position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.

The idea behind Adhera Therapeutics and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.